PubMed Health⌕ Search

Biomedical subjects

B J Erasmus

Publications and source records attributed to B J Erasmus.

At least 37 records · Page 2Linked to original sources
PubMed1986

Comparative pathogenicity and antigenic cross-reactivity of Rift Valley fever and other African phleboviruses in sheep.

Homologous and heterologous haemagglutination-inhibition (HAI), complement-fixation (CF), immunodiffusion (ID) and mouse neutralization tests were performed with the Lunyo (LUN) and a Zimbabwean strain of Rift Valley fever (RVF) virus, the prototype and a South African strain of Arumowot (AMT) virus and prototype strains of Gordil (GOR), Saint-Floris (SAF) and Gabek Forest (GF) viruses, using immune mouse ascitic fluids prepared against these viruses. Reactions of identity occurred in all tests between LUN and the Zimbabwean strains of RVF and between the two strains of AMT virus. Otherwise, cross-reactions occurred between all the phleboviruses in HAI tests, while reactions in CF, ID and neutralization tests were monospecific for virus serotypes, except that weak cross-reaction occurred between GOR and SAF viruses in CF and ID tests. Four sheep infected subcutaneously with the Zimbabwean strain of RVF virus developed transient fever, viraemia, leucopaenia, relative thrombocytopaenia, haemoconcentration and raised serum enzyme levels, which indicated that the sheep had developed necrotic hepatitis. Disseminated focal necrotic hepatitis was confirmed in a sheep killed for examination on day 4 post-infection. The other three sheep recovered uneventfully after only mild depression and anorexia. Groups of three sheep infected with SAF, GOR, AMT and GF viruses had no demonstrable viraemia or other sign of infection or illness, except that the sheep infected with AMT developed mild fever lasting less than 24 h. Antibody responses were monitored at intervals over a period of 24 weeks in all sheep by homologous and heterologous HAI, CF and cell culture neutralization (CPENT) tests. Homologous antibody responses were marked in the RVF-infected sheep and their sera cross-reacted strongly in HAI tests with antigens of the other viruses. The sera of the RVF-infected sheep cross-reacted less markedly in CF and CPENT tests. Homologous antibody responses were poor in all the sheep infected with phleboviruses other than RVF, and the cross-reactivity of their sera for RVF antigen or virus was negligible. All sheep were challenged with RVF virus 48 weeks after their initial infection. The sheep which had originally been infected with RVF virus were immune and developed neither fever nor viraemia. All other sheep developed fever, viraemia and antibodies to RVF virus. It was concluded that the African phleboviruses, other than RVF, are unlikely to cause disease in livestock or to induce antibodies which could cause confusion in the diagnosis of RVF.

Animals↗
PubMed1985

Immune response against the purified serotype specific antigen of bluetongue virus and initial attempts to clone the gene that codes for the synthesis of this protein.

Sheep were injected with different amounts of purified protein P2 of bluetongue (BT) virus (BTV). About 3 X 50 mcg was required for the induction of neutralizing antibodies. Sheep injected with 3 X 10 mcg were, however, still largely protected when challenged with virulent virus. This has suggested the possibility of using P2 as a subunit vaccine and initiated an investigation of the possibility of synthesizing P2 by DNA-recombinant technology. In order to clone the gene that codes for the synthesis of P2 both the "shotgun" approach with unfractionated dsRNA and cloning of isolated segment 2 were investigated. The basic approach was to convert the dsRNA to DNA which was cloned into the Pst 1 site of E. coli plasmid pBR322. The largest BTV-specific insert that was obtained in the initial experiments was just more than 2,000 base pairs long. The largest insert obtained when isolated segment 2 dsRNA was cloned was about 1,200 base pairs which represents about 1/3 of the P2 gene.

Antibodies, Viral↗
PubMed1981

Identification of the serotype-specific and group-specific antigens of bluetongue virus.

The bluetongue virus (BTV) core particle contains 2 major polypeptides, P3 and P7, and is surrounded by an outer capsid layer that is composed of the 2 major polypeptides, P2 and P5. Analysis of the immune precipitates from soluble 14C-labelled BTV polypeptides and hyper-immune rabbit and guinea-pig sera indicated that polypeptide P2 precipitates only with homologous BTV sera. This would indicate that P2 is the main determinant of serotype specificity. It was also found that in sheep infected with BTV the P2-precipitating antibodies in the serum correlate with the neutralizing antibody titres, whereas the appearance and subsequent decline of P7-precipitating antibodies correspond well with those of the complement fixing antibodies. This suggests that BTV group specificity, as measured by a complement fixation tests, is determined by the core protein P7. This result was supported by the observation that mouse ascitic fluid, which contains a high titre of BTV-specific complement fixing antibodies and a very low titre of neutralizing antibodies, contains almost exclusively antibodies that precipitate P7.

Animals↗
PubMed1975

Bluetongue in sheep and goats.

A description is given of the symptomatology, pathology and pathogenesis of bluetongue in sheep and goats. The economic significance of the disease in South Africa is discussed.

Animals↗
PubMed1975

The epizootiology of bluetongue: the African situation.

Bluetongue virus is transmitted biologically by various species of Culicoides, notably C. pallidipennis and C. variipennis. Factors such as rainfall, temperature and relative altitude, which influence the breeding of the insect vectors also govern the incidence and distribution of the disease. The host range of bluetongue virus includes sheep, cattle, goats and various antelopes. Many other, as yet unidentified hosts could perhaps harbour the virus and influence the epizootiology of the disease. The close relationship between C. pallidipennis and cattle is indicated and the efficient mechanism for virus maintenance which this relationship constitutes is emphasised. It is further postulated that sheep are not essential for the continued survival of bluetongue virus, but merely function as accidental or indicator hosts.

Africa, Southern↗
PubMed1975

The control of bluetongue in an enzootic situation.

On account of the wide host range of bluetongue virus and its biological transmission by insects, control of the disease in an enzootic situation is based primarily on the active immunisation of susceptible animals as well as on the prevention of contact between the insect vectors and the susceptible hosts. In spite of their unquestionable value, the egg attenuated vaccines which are currently employed for prophylactic immunisation, have certain shortcomings. The existence of 16 known serotypes of bluetongue virus makes it difficult to achieve a very wide spectrum of immunity in sheep vaccinated once or twice only. The problems which are experienced with the immunisation of lambs born in spring are indicated. The present vaccine can also present problems when used in breeding animals. Furthermore, the costs involved in the annual vaccination of large numbers of animals are considerable. The need for a vaccine for cattle is indicated. Work is also being conducted at present on the development of an inactivated vaccine for use in sheep. The use of novel virological techniques may aid in the future development of absolutely safe and highly efficient vaccines against bluetongue.

Animals↗